Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
$757M |
| 2 |
Microsoft
MSFT
|
$725M |
| 3 |
Apple
AAPL
|
$628M |
| 4 |
Amazon
AMZN
|
$487M |
| 5 |
Meta Platforms (Facebook)
META
|
$355M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
$121M |
| 2 |
KE Holdings
BEKE
|
$31.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$24.4M |
| 4 |
X
US Steel
X
|
$18.4M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
$15.6M |
Sector Composition
| 1 | Technology | 34.97% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Communication Services | 10.31% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Monro
MNRO
$494M
| $853K | ﹤0.01% |
57,242
-1,600
| -3% | -$23.9K |
|
|
DCBO
2202
Docebo
DCBO
$884M
| $852K | ﹤0.01% |
29,525
| – | – |
|
2203
Arhaus
ARHS
$1.58B
| $852K | ﹤0.01% |
98,300
| – | – |
|
2204
MGP Ingredients
MGPI
$624M
| $851K | ﹤0.01% |
28,400
-1,400
| -5% | -$42K |
|
|
GMRE
2205
Global Medical REIT
GMRE
$490M
| $850K | ﹤0.01% |
122,700
| – | – |
|
2206
Evolus
EOLS
$485M
| $845K | ﹤0.01% |
91,700
| – | – |
|
2207
Mineralys Therapeutics
MLYS
$1.91B
| $838K | ﹤0.01% |
+61,900
| New | +$838K |
|
2208
Nuvation Bio
NUVB
$1.01B
| $832K | ﹤0.01% |
426,700
| – | – |
|
2209
Axogen
AXGN
$723M
| $827K | ﹤0.01% |
76,200
-4,800
| -6% | -$52.1K |
|
2210
Peapack-Gladstone Financial
PGC
$511M
| $819K | ﹤0.01% |
29,000
| – | – |
|
|
NOA
2211
North American Construction
NOA
$398M
| $818K | ﹤0.01% |
51,300
+4,200
| +9% | +$66.9K |
|
2212
Day One Biopharmaceuticals
DAWN
$758M
| $818K | ﹤0.01% |
125,800
+18,300
| +17% | +$119K |
|
2213
Fortrea Holdings
FTRE
$909M
| $816K | ﹤0.01% |
165,120
| – | – |
|
2214
LendingTree
TREE
$924M
| $816K | ﹤0.01% |
22,000
| – | – |
|
2215
The RealReal
REAL
$882M
| $814K | ﹤0.01% |
170,000
+10,600
| +7% | +$50.8K |
|
2216
Five Star Bancorp
FSBC
$696M
| $813K | ﹤0.01% |
28,496
-700
| -2% | -$20K |
|
2217
Compass Diversified
CODI
$544M
| $812K | ﹤0.01% |
129,300
-2,700
| -2% | -$17K |
|
2218
Riskified
RSKD
$740M
| $811K | ﹤0.01% |
162,513
-5,800
| -3% | -$28.9K |
|
2219
Stagwell
STGW
$1.45B
| $801K | ﹤0.01% |
178,100
| – | – |
|
2220
Aspen Aerogels
ASPN
$549M
| $800K | ﹤0.01% |
135,200
| – | – |
|
2221
Tilray
TLRY
$1.37B
| $799K | ﹤0.01% |
1,928,138
+111,500
| +6% | +$46.2K |
|
2222
A-Mark Precious Metals
AMRK
$580M
| $798K | ﹤0.01% |
36,000
| – | – |
|
2223
Rush Enterprises Class B
RUSHB
$4.48B
| $798K | ﹤0.01% |
15,200
+500
| +3% | +$26.2K |
|
2224
Caleres
CAL
$500M
| $797K | ﹤0.01% |
65,200
| – | – |
|
2225
Eve Holding
EVEX
$1.2B
| $792K | ﹤0.01% |
115,400
| – | – |
|